Read our Pleio Ponderings, case studies, news, white papers, blog posts, and webinars to gain insight on the industry.
In a new byline for MedCity News, Pleio CEO Michael Oleksiw argues that healthcare’s rush to automate patient engagement is outpacing the trust patients actually have in AI-led care. Drawing a parallel to Waymo’s Senate testimony on remote human operators, Oleksiw makes the case that fear, isolation, and eroded trust — not logistics — are the real drivers of medication nonadherence.
Asembia 2026 brought the specialty pharmacy world together and the conversations are still resonating. Pleio CEO Michael Oleksiw and Chief Experience Officer Abby Reynolds, PharmD sat down with the Pharmacy Podcast Network for their annual Asembia Rewind, alongside leaders from across the specialty ecosystem.
Where emotion drives action through the written word.
Discover how loneliness by age impacts patient needs—and why human connection still matters in a healthcare system dominated by digital tools.
Gain contextual, in-depth knowledge about a specific real-world subject.
Pleio analyzed over 140,000 real patient conversations through its AI-powered platform, OLLIE, to uncover what truly disrupts medication adherence. This analysis is based on the foundation of Pleio’s Barrier Blueprint, which organizes the complexity of adherence into seven dimensions, 37 drivers, and 85 distinct barriers
Pleio reaches more patients with a human-first approach to adherence.
Patients diagnosed with a mental health condition requires heightened emotional support beyond traditional patient support programs.
Learn and discover with our podcasts and webinars
On “The Tech Glow Up” live from HLTH 2025, Vital.io and Pleio share how AI can make healthcare more human—from translating medical jargon to uncovering emotional barriers that hinder adherence and patient trust.